Skip to main content

Table 2 Clinical and experimental studies using cell therapy for retinal diseases

From: Stem cell therapy for retinal diseases: update

Study

Type of study

Type of injury or illness

Route used

Type and source of cells

Otani, et al. [16]

Experimental study in animals

Mice with retinal degenerative disease

Intravitreous transplantation

Adult bone marrow-derived lineage-negative hematopoietic stem cells

Wang, et al. [48]

Experimental study in animals

Retinitis pigmentosa

Tail vein

Pluripotent bone marrow-derived mesenchymal stem cells

Li, et al. [93]

Experimental study in animals

Rat injured by ischemia/reperfusion

Intravitreous transplantation

Bone marrow mesenchymal stem cells

Uteza, et al. [94]

Experimental study in animals

Photoreceptor cell degeneration in Royal College of Surgeon rats

Intravitreous transplantation

Encapsulated fibroblasts

Zhang and Wang [95]

Experimental study in animals

Light-damaged retinal structure

Subretinal space

Bone marrow mesenchymal stem cells

Tomita, et al. [96]

Experimental study in animals

Retinas mechanically injured using a hooked needle

Intravitreous transplantation

Bone marrow-derived stem Cells

Meyer, et al. [97]

Experimental study in animals

Retinal degeneration

Intravitreous transplantation

Embryonic stem cells

Siqueira, et al. [21]

Experimental study in animals

Chorioretinal injuries caused by laser red diode 670N-M

Intravitreous transplantation

Bone marrow-derived stem cells

Wang, et al. [98]

Experimental study in animals

Mice with laser-induced retinal injury

Intravitreous transplantation

Bone marrow-derived stem cells

Johnson, et al. [99]

Experimental study in animals

Glaucoma

Intravitreous transplantation

Bone marrow-derived mesenchymal stem cell

Castanheira, et al. [37]

Experimental study in animals

Rat retinas submitted to laser damage

Intravitreous transplantation

Bone marrow-derived mesenchymal stem cell

Jonas, et al. [32]

Case report

Patient with atrophy of the retina and optic nerve

Intravitreous transplantation

Bone marrow-derived mononuclear cell transplantation

Jonas, et al. [33]

Case report

Three patients with diabetic retinopathy, age-related macular degeneration, and optic nerve atrophy (glaucoma)

Intravitreous transplantation

Bone marrow-derived mononuclear cell transplantation

Siqueira, et al. [34] ClinicalTrials.gov identifier NCT01068561 [19]

Clinical trial Phase I

Five patients with retinitis pigmentosa

Intravitreous transplantation

Bone marrow-derived mononuclear cell transplantation

Siqueira [92] Ethics committee of Brazil Register: 16018

Clinical trial Phase II

Fifty patients with retinitis pigmentosa

Intravitreous transplantation

Bone marrow-derived mononuclear cell transplantation

Siqueira [92] Ethics committee of Brazil Register: 15978

Clinical trial Phases I/II

Ten patients with macular degeneration

Intravitreous transplantation

Bone marrow-derived mononuclear cell transplantation

Siqueira [92] Ethics Committee of Brazil Register: 16062

Clinical trial Phases I/II

Thirty patients with ischemic retinopathy

Intravitreous transplantation

Bone marrow-derived mononuclear cell transplantation

Advanced Cell Technology Inc. [100]

Clinical trial Phases I/II

Twelve patients with Stargardt macular dystrophy

Subretinal transplantation

Retinal pigment epithelial cells derived from human embryonic stem cells